Hot Sliver Stocks To Own For 2014

The Dow Jones Industrials (DJINDICES: ^DJI  ) got off to a strong start this morning, posting a 106-point gain by 10:55 a.m. EDT based largely on continuing optimism about the pace of the U.S. economic recovery. With Friday's jobs report sending bond yields soaring and bond prices crashing late last week, investors using asset-allocation strategies likely saw the news as mixed for their overall portfolios. Still, the stock market has held up quite well in July, as the Federal Reserve isn't spooking markets about the potential end of its quantitative-easing program nearly as much as it did last month.

Still, investors should take today's gains with a grain of salt, because two major events will soon take the focus off economic data. After the closing bell today, Alcoa will kick off earnings season, and the market has a lot riding on the results it will see in the coming weeks. Secondly, on Wednesday the Fed will release its latest Federal Open Market Committee minutes, which will provide some more context for the June decision that sparked such strong reactions from investors when it was first released.

Top 10 Building Product Stocks To Invest In Right Now: Gilead Sciences Inc.(GILD)

Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fost er City, California.

Advisors' Opinion:

• [By Victor Reklaitis]

  Biogen Idec Inc. (BIIB) �and Gilead Sciences Inc. (GILD) �were among the biotech stocks that slumped during the past week, falling 7.7% and 4.9%. Investors yanked money out of biotech and health-care funds at the heaviest pace of weekly outflows since December 2011.

• [By Sean Williams]

  A new drug emerges
  A little more than a week ago, Gilead Sciences (NASDAQ: GILD  ) received approval for its oral hepatitis-C drug, Sovaldi (previously sofosbuvir) for the treatment of genotypes 1 through 4. According to the World Health Organization there are 11 hepatitis-C subtypes, but for all intents and purposes, genotype 1 (by far the most common), 2, and 3 comprise somewhere around 95% of all hepatitis-C cases based on every meta-analysis trial I've ever stumbled across.

• [By Brian Orelli]

  The most advanced second-generation hepatitis C drugs, Johnson & Johnson's (NYSE: JNJ  ) simeprevir and Gilead Sciences' (NASDAQ: GILD  ) sofosbuvir, are already being reviewed for approval by the FDA. They both should be approved by the end of the year.

• [By Ben Levisohn]

  Today, at least, it doesn’t look like Celgene will have to sacrifice anything. Shares of Celgene have gained 2.6% to $153.97 at 2:30 p.m. today, a day which has been good for biotech stocks generally. Gilead Sciences (GILD) has risen 1.4% to $82.03, Biogen Idec (BIIB) has advanced 2.2% to $306.38 and Regeneron Pharmaceuticals (REGN) is up 2.6% at $305.89.

Hot Sliver Stocks To Own For 2014: Bio-Reference Laboratories Inc.(BRLI)

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. It offers various chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology, and other tissue analysis. The company also operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data, and other data sources to provide administrative and clinical decision support systems. In addition, it operates a Web-based connectivity portal solution for laboratories and physicians to provide laboratory ordering and results to physician customers. The company provides its services directly to physicians, geneticists, hospitals, clinics, and correctional and other health facilities. Bio-Refe rence Laboratories, Inc. was founded in 1981 and is headquartered in Elmwood Park, New Jersey.

Advisors' Opinion:

• [By Lauren Pollock]

  Bio-Reference Laboratories Inc.(BRLI) projected fiscal-fourth quarter earnings below expectations and also gave a cautious view for the recently started fiscal year. The clinical-testing company said it has been under pressure from reimbursement rates, higher costs stemming from upgrading acquisitions in Florida and California, as well as substantial start-up costs for its inherited cancer program.

• [By Geoff Gannon]

  But if you can definitely hold a company through a tough market that lasts a few years ��then you can look for a wonderful business to buy and hold at any time. In any market. I found some lovely businesses around the time of the 2000 market peak. They just weren�� big caps, dot coms, etc. They were smaller more mundane businesses. In at least one case ��Bio-Reference Labs (BRLI) ��I made some money (it seemed like a scary big amount at the time) holding the stock for about 2 years but I would��e made a whole lot more if I had just held that one stock through till today. And even now BRLI seems a fine stock to keep holding. So, you see I could��e saved myself a lot of trouble by holding something for more than 10 years. And it wouldn�� have hurt my performance at all. In fact, BRLI has beaten the market by a lot for a very long time. And, yes, the price I paid for BRLI happens to be the most I ever paid for a stock relative to its record earnings. So, I paid a very high price ��for a value investor like me ��for a stock that promptly went on to return around 20% a year for the next 10 years and is now back at almost the exact same P/E ratio where I first bought it.

• [By Ben Levisohn]

  Some easy money from the European Central Bank helped boost stocks today, as Caterpillar (CAT), Joy Global (JOY),�Bio-Reference Laboratories (BRLI) and Amazon.com (AMZN) rose.

• [By Ben Levisohn]

  As a result, LabCorp has dropped 11% to $87.79 and has helped drag down competitors like Quest Diagnostics (DGX), and BioReference Laboratories (BRLI).

Hot Sliver Stocks To Own For 2014: Books-A-Million Inc.(BAMM)

Books-A-Million, Inc. operates as a book retailer in the southeastern United States. The company operates superstores and traditional bookstores that offer a selection of hardcover and paperback books, magazines, and newspapers. It also offers other merchandise, including gifts, cards, collectibles, magazines, music, DVDs, and electronic accessories, as well as coffee, tea, and other edible products. The company markets its products under the trademarks of Books-A-Million, BAM! Books-A-Million, Bookland, Books & Co., Millionaire?s Club, Sweet Water Press, Thanks-A-Million, Big Fat Coloring Book, Up All Night Reader, Read & Save Rebate, Readables Accessories for Readers, Kids-A-Million, Teachers First, The Write-Price, Bambeanos, Hold That Thought, Book$mart, BAMM, BAMM.com, BOOKSAMILLION.com, Chillatte, Joe Muggs Newsstand, Page Pets, JOEMUGGS.com, FAITHPOINT.com, Faithmark, Joe Muggs, Anderson?s Bookland, Snow Joe, Summer Says, On the John University, OTJU, American Whole sale Book Company, AWBC, and NetCentral. It also offers its products over the Internet at Booksamillion.com. As of August 11, 2011, the company operated 231 stores in 23 states and the District of Columbia. Books-A-Million, Inc. was founded in 1917 and is based in Birmingham, Alabama.

Advisors' Opinion:

• [By John Udovich]

  Vitamin Shoppe Inc (NYSE: VSI), Books-A-Million, Inc (NASDAQ: BAMM) and Perfumania Holdings, Inc (NASDAQ: PERF) have the dubious distinction of being�the worst performing small cap�specialty retail stocks for this year (according to Finviz.com) with losses of 4.85% and�3% and a gain of 0.61%, respectively, since the start of the year (See my previous article: This Year�� Best Performing Small Cap Specialty Retail Stocks? UNTD, TA & HZO). I should mention that the definition of specialty retail stocks might vary from one stock screener to another, but what�� clear is that these three small cap retail stocks have been heading in the wrong direction for investors for much of this year. �With that in mind, what sort of performance should investors expect from these small cap specialty retail stocks on Black Friday and for the all important holiday season? Here is what you need to be aware of:

Hot Sliver Stocks To Own For 2014: Fortegra Financial Corporation (FRF)

Fortegra Financial Corporation, an insurance services company, provides distribution and administration services primarily in the United States. The company�s Payment Protection segment delivers credit insurance, debt protection, warranty and service contracts, and motor club solutions under the Life of the South, Continental Car Club, United Motor Club, and Auto Knight Motor Club brand names to consumer finance companies, regional banks, community banks, retailers, small loan companies, warranty administrators, automobile dealers, vacation ownership developers, and credit unions. This segment specializes in providing products that protect consumer lenders and their borrowers from death, disability, or other events that could impair their borrowers' ability to repay a debt. Fortegra Financial Corporation�s Business Process Outsourcing segment offers various administrative services under the Consecta and Pacific Benefits Group Northwest, LLC brand names to insurance and o ther financial services companies. This segment�s services include sales and marketing, electronic underwriting, premium billing and collections, policy administration, claims adjudication, and call center management services. The company�s Brokerage segment sells specialty property and casualty, and surplus lines insurance to retail insurance brokers and agents, and insurance companies under the Bliss & Glennon, eReinsure.com, Inc., and South Bay Acceptance Corporation brand names. This segment also provides its clients the ability to obtain various types of commercial insurance coverage outside of their core areas of focus. In addition, it offers insurance underwriting services as a managing general agent for specialized insurance carriers. The company was formerly known as Life of the South Corporation and changed its name to Fortegra Financial Corporation in 2008. The company was incorporated in 1981 and is based in Jacksonville, Florida.

Advisors' Opinion:

• [By Hilary Kramer]

  I am a big fan of financials, which is why I named Fortegra Financial (FRF) as the best stock of 2014. Fortegra isn�� your traditional bank or financial company, but it has great potential.

Hot Sliver Stocks To Own For 2014: NXP Semiconductors N.V.(NXPI)

NXP Semiconductors N.V., through its subsidiary, NXP B.V., provides mixed signal solutions and standard products worldwide. The company provides amplifiers, audio/radio products, bipolar transistors, data converters, diodes, identification and security products, interface and connectivity products, logic devices, media processors, microcontrollers, MOSFETs, power management integrated circuits (IC), radio frequency devices, sensors, thyristors, television and set-top-box front ends, and logic driver and controller ICs, as well as ESD, EMI, and signal conditioning products. Its products are used in automotive, identification, wireless infrastructure, lighting, mobile, consumer, computing, and industrial applications. NXP Semiconductors N.V. markets its products directly and through distribution to various original equipment manufacturers, original design manufacturers, contract manufacturers, and distributors. The company was formerly known as KASLION Acquisition B.V and ch anged its name to NXP Semiconductors NV in May 2010. NXP Semiconductors N.V. was founded in 2006 and is headquartered in Eindhoven, the Netherlands.

Advisors' Opinion:

• [By MONEYMORNING]

  In other words, Allegion's offerings range from low-tech - steel doors and conventional locks - to high tech: automated-access and security systems, video monitoring, and systems integration. Its 23 business brands include:

  Interflex Datensysteme GmbH & Co. KG, which offers such workforce-management systems as time accounting and automated scheduling, as well as security systems that include ID and access-card production, closed-circuit (CCTV) video surveillance, and biometrics. CISA, a security pioneer that patented the first electrically controlled lock - back in 1926. It is also the first brand in the world to develop smart-card locks, which are used as electronic keys to safely and efficiently manage gates and entrances. CISA today develops and markets cylinders and locks for any kind of door, including electronic locks, panic bars, door closers, safes, and padlocks. aptiQ Smart Technology, which uses an "open-architecture" to design readers, credentials, and smartphone-based security applications. The aptiQ portfolio includes easy-to-use readers that can accommodate most magnetic-stripe cards. This product line also allows for the creation and use of proximity cards, aptiQ "smartcards," and the latest in so-called "near-field communications" (NFC) technology - the know-how behind our May 2012 recommendation of NXP Semiconductors NV (Nasdaq: NXPI), a stock that has more than doubled. (Coincidentally, NXP is a 2006 spinoff from Koninklijke Philips Electronics NV (NYSE ADR: PHG) - which underscores, again, the profit potential of "spin-off investing.") Bocom Systems, which specializes in video monitoring solutions for city and highway traffic, as well as for airports, government buildings, and general surveillance. That business unit designs, engineers, and installs both security alarm systems and more-complex closed-circuit-based security networks. And Schlage, a 90-year-old company that's one of the top nam
• [By MONEYMORNING.COM]

  176.5% on NXP Semiconductors NV (Nasdaq: NXPI), which we'd recommended in May 2012 at $23.40 a share, and then re-recommended a number of times thereafter. Shares of the near-field-communications (NFC) chipmaker hit a new lifetime high of $64.69 this month and are still 168% higher than when we first told you about them.

• [By Paul Ausick]

  NXP Semiconductors N.V. (NASDAQ: NXPI) not only makes parts for the iPhone, but will benefit from the build-out of China Mobile’s base station infrastructure. The wireless carrier plans to support more than 500,000 base stations by the end of 2014, up from around 200,000 today. The stock closed on Friday at $43.52, in a 52-week range of $24.66 to $44.75. Sterne Agee’s price target on the stock is $50.00, yielding an upside potential of 14.9%. The consensus estimate for the 2014 fiscal year is $4.07, and the forward multiple at that level is 10.69. Shares were up 3.3% in premarket trading this morning.

• [By Selena Maranjian]

  Westfield Capital Management reduced its stake in lots of companies, including NXP Semiconductors (NASDAQ: NXPI  ) , which specializes in near-field communications (NFC) chips. Some of its chips aid digital video surveillance, while others can help cars talk to each other. NXP's NFC business has been growing briskly, and while there is competition from other firms, management sees that as a good sign and recently offered rosy projections.

Hot Sliver Stocks To Own For 2014: Arlington Asset Investment Corp (AI)

Arlington Asset Investment Corp. is a principal investment firm that acquires mortgage-related and other assets. The Company acquires residential mortgage-backed securities (MBS), either issued by United States government agencies or guaranteed as to principal and interest by United States government agencies or United States government-sponsored entities (agency-backed MBS). It also acquires MBS issued by private organizations (private-label MBS). It manages a portfolio of mortgage holdings with the goal of obtaining a high risk-adjusted return on capital. The Company acquires direct interests in residential MBS guaranteed as to principal and interest by Fannie Mae or Freddie Mac.

The Company focuses on acquiring Fannie Mae MBS and Freddie Mac MBS. It also acquires and holds non-agency private-label MBS. Private-label MBS are MBS that are not issued by the United States Government agency or a United States Government-sponsored entity, such as Fannie Mae or Freddie Mac, and that are generally backed by a pool of single-family residential mortgage loans. Certificates are issued by originators of, investors in, and other owners of residential mortgage loans, including savings and loan associations, savings banks, commercial banks, mortgage banks, investment banks and special purpose conduit subsidiaries of these institutions. The Company focuses on acquiring Residential Prime Senior MBS, Residential Non-Prime Senior MBS, Residential Subordinate MBS and Residential Re-REMIC Support MBS.

Advisors' Opinion:

• [By Eric Volkman]

  Arlington Asset Investment (NYSE: AI  ) continues to distribute some of its take in the form of shareholder payouts. The company has declared a dividend for its Q2 of $0.875 per share. This will be paid on July 31 to shareholders of record as of June 28. That amount matches each of the firm's preceding quarterly distributions stretching back to mid-2011. Prior to that, it handed out $0.75 per share.

• [By victorselva]

  The Charles Schwab Corporation (SCHW) is a savings and loan holding company. The company is engaged, through its subsidiaries, in securities brokerage, banking, money management, and financial advisory services. Its subsidiaries include Charles Schwab & Co. (a leading discount broker-dealer), Charles Schwab Investment Management (a mutual fund investment advisor) and Charles Schwab Bank.In this article, let's take a look at this brokerage firm and try to explain to investors the reasons this is an apparently appealing investment opportunity.The FocusThe company provides financial services to individuals and institutional clients through two segments: Investor Services and Institutional Services. The Investor Services segment provides retail brokerage and banking services to individual investors. The Institutional Services segment provides custodial, trading, and support services to independent investment advisors. The Institutional Services segment also provides retirement plan services, specialty brokerage services, and mutual fund clearing services. The company seeks to meet the financial services needs of investors, advisers and employers. It focuses on building client loyalty with the goal of attracting new clients and serving them. Additionally, Schwab麓s strengths through shared core processes and technology advances which help create services that are scalable and consistent with the business.Interest Rates, Capital Structure and Debt-to-Capital RatioThe results are dependent on short-term interest rates, as 37% of its top line came from net interest income in the first quarter of 2014.The broker has been making significant efforts to become less dependent on interest rates, which we expect Federal Reserve will raise them in late 2014 or 2015. Also, the company麓s plan is to reach a low-cost capital structure and targets a long-term debt-to-total financial capital ratio of less than 30%.Lucrative Derivatives Trading In 2011, the company acquired Compl